EdiGene
PrivateLast Round
Series B
Extension
Apr 21, 2021
Total Funding Raised
$175M
Momentum Score
50 /100
Company Overview
EdiGene is a biotechnology company specializing in advanced genome editing technologies to enhance drug discovery and create innovative therapeutics for various genetic disorders and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EdiGene Comps
Public and private peers based on sector, stage, and business model.
EdiGene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 21, 2021 | ||||
| Series B | Oct 13, 2020 | ||||
| Series A Extension | Sep 16, 2019 | ||||
| Series A Extension | Feb 4, 2019 | ||||
| Series A Extension | Aug 8, 2018 |
EdiGene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Series B Extension, Series B |
| BioTrack Capital | Series B Extension |
| BGI Co-Win | Series A Extension |
| Loyal Valley Capital | Series B Extension |
| WI Harper Group | Series A, Series A Extension |
| IDG Capital | Series A Extension, Series B Extension, Series B, Series A |
| CAS Venture Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 144% MoM.
- Apr 15, 2026
Monthly visitors grew 120% MoM.
EdiGene Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EdiGene's valuation, stock price, and market status.
